Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Board Committees

Cardiff Oncology has the committees listed below in place.  The grid below provides an overview of the individuals that make up each committee.  To learn more about a particular committee or an individual member click the titles below.